![Richard Peters](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Peters
Président chez
APREA THERAPEUTICS, INC.
Fortune : 159 746 $ au 31/07/2026
Profil
Richard Peters was the founder of X4 Pharmaceuticals, Inc. (2014), X4 Pharmaceuticals, Inc. (2010), MedNav, Inc. (1997) where the title held was Chief Executive Officer, and PIC Therapeutics, Inc. (2016) where the title held was Director.
Dr. Peters is also the founder of Tellbio, Inc. Dr. Peters is currently the President, Chief Executive Officer & Director at Yumanity, Inc., Chairman at Pharming Group NV since 2023, and Chairman at Aprea Therapeutics, Inc. since 2020.
Former positions include President, Chief Executive Officer & Director at Merrimack Pharmaceuticals, Inc. (2017-2019), President, CEO, Secretary, Treasurer & Director at Yumanity Therapeutics, Inc. (2020-2022), Director-Medical Affairs at Amgen, Inc. (2003-2006), Senior Director at Onyx Pharmaceuticals, Inc. (2006-2008), Lead Independent Director at Kineta, Inc. (2022-2025), and Senior Vice President & Head-Global Rare Diseases at Genzyme Corp.
(2008-2017).
Education includes a doctorate from The Medical University of South Carolina and an undergraduate degree from College of Charleston.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PHARMING GROUP NV 0,02% | 28/05/2026 | 156 186 ( 0,02% ) | 157 812 $ | 31/07/2026 |
| 16/06/2026 | 3 119 ( 0,03% ) | 1 934 $ | 31/07/2026 |
Postes actifs de Richard Peters
| Sociétés | Poste | Début |
|---|---|---|
| APREA THERAPEUTICS, INC. | Président | 23/08/2023 |
| PHARMING GROUP N.V. | Président | 25/09/2023 |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Provides transforming drug discovery for neurodegenerative diseases services | Directeur Général | - |
Tellbio, Inc.
 Tellbio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops circulating tumor cell diagnostic technologies for detection, monitoring and treatment of cancer | Fondateur | 01/01/2019 |
Anciens postes connus de Richard Peters
| Sociétés | Poste | Fin |
|---|---|---|
| KINETA, INC. | Directeur/Membre du Conseil | 30/06/2025 |
PIC Therapeutics, Inc.
 PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Fondateur | 01/06/2022 |
| YUMANITY THERAPEUTICS | Directeur Général | 01/01/2022 |
| MERRIMACK PHARMACEUTICALS | Directeur Général | 28/06/2019 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/01/2017 |
Formation de Richard Peters
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
69
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
X4 Pharmaceuticals, Inc. /Old/
 X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and distributes oral small molecule CXCR4 antagonists | Health Technology |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
Pharming Group NV
 Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
Medical University of South Carolina
 Medical University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
College of Charleston
 College of Charleston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedNav, Inc.
 MedNav, Inc. Packaged SoftwareTechnology Services Develops mobile health applications | Technology Services |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Provides transforming drug discovery for neurodegenerative diseases services | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Aprea Therapeutics, Inc.
 Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
Tellbio, Inc.
Tellbio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops circulating tumor cell diagnostic technologies for detection, monitoring and treatment of cancer | Commercial Services |
PIC Therapeutics, Inc.
PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Health Technology |
Yumanity Therapeutics, Inc.
 Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Kineta, Inc.
 Kineta, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
